DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
L-Citrulline is an investigational drug.
There have been 19 clinical trials for L-Citrulline. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Syndrome, Anemia, Sickle Cell, and Muscular Dystrophy, Duchenne. The leading clinical trial sponsors are Asklepion Pharmaceuticals, LLC, Masih Daneshvari Hospital, and Angiogenix.
There is one US patent protecting this investigational drug and twenty-one international patents.
Recent Clinical Trials for L-Citrulline
|Intravenous L-Citrulline to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness||Asklepion Pharmaceuticals, LLC||Phase 2|
|Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes||National Heart, Lung, and Blood Institute (NHLBI)||Phase 2|
|Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes||National Institutes of Health (NIH)||Phase 2|
Top disease conditions for L-Citrulline
Top clinical trial sponsors for L-Citrulline
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|L-Citrulline||Start Trial||Seaweed-derived cosmetic compositions||Skinergistics Clinical Skin Solutions Inc. (Vancouver, CA)||Start Trial|
|L-Citrulline||Start Trial||Methods for control of flux in metabolic pathways through enzyme relocation||The Board of Trustees of the Leland Stanford Junior University (Stanford, CA) GreenLight Biosciences, Inc. (Medford, MA)||Start Trial|
|L-Citrulline||Start Trial||Methods, systems, and arrays for biomolecular analysis||Vibrant Holdings, LLC (San Carlos, CA)||Start Trial|
|L-Citrulline||Start Trial||Hair dyeing process using at least one ortho-diphenol and one organic salt of titanium and of a carboxylic acid||L'OREAL (Paris, FR)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|L-Citrulline||European Patent Office||EP2566953||2030-05-07||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|